{"id":8824,"date":"2026-09-01T08:44:13","date_gmt":"2026-09-01T08:44:13","guid":{"rendered":"https:\/\/www.vanguardlifesciences.co.uk\/?p=8824"},"modified":"2026-09-01T08:44:32","modified_gmt":"2026-09-01T08:44:32","slug":"vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer","status":"publish","type":"post","link":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/","title":{"rendered":"Vanguard Life Sciences begr\u00fc\u00dft Rebecca Lythe als Group Chief Executive Officer"},"content":{"rendered":"
\"\"<\/figure>\n

Rebecca kommt zu einem spannenden Zeitpunkt in der Entwicklung von Vanguard Life Sciences zu uns, da wir weiterhin auf der Erfahrung der Gruppe bei der Bereitstellung komplexer Infrastrukturen in stark regulierten Umgebungen aufbauen und dieses Fachwissen auf die Bereiche Pharmazie, Biotechnologie und Forschung anwenden.<\/p>\n

Sie verf\u00fcgt \u00fcber umfassende Erfahrung in den Bereichen Strategie, Transformation, Innovation, Unternehmensf\u00fchrung und operative Leitung. Rebecca wechselt nach sieben Jahren bei der Specsavers Group zu Vanguard, darunter mehr als vier Jahre als Gesch\u00e4ftsf\u00fchrerin von Newmedica, wo sie das Wachstum und die Entwicklung eines der f\u00fchrenden Anbieter spezialisierter Augenheilkunde in Gro\u00dfbritannien leitete.<\/p>\n

Rebecca bringt au\u00dferdem Erfahrung aus leitenden Positionen bei Specsavers und ASDA mit, nachdem sie zuvor bei KPMG t\u00e4tig war.<\/p>\n

Unterst\u00fctzung der n\u00e4chsten Phase von Vanguard Life Sciences<\/h2>\n

Die 2026 gegr\u00fcndete Sparte Vanguard Life Sciences erweitert die Expertise der Gruppe im Bereich moderner Bauweisen auf fortschrittliche Reinraum-, Labor- und Containment-Umgebungen.<\/p>\n

Vanguard Life Sciences arbeitet mit Organisationen aus den Bereichen Pharmazie, Biotechnologie und Forschung zusammen und bietet spezialisierte Infrastruktur, die auf die Anforderungen komplexer und regulierter Umgebungen zugeschnitten ist, mit einem Fokus auf Qualit\u00e4t, Geschwindigkeit und Flexibilit\u00e4t.<\/p>\n

Rebecca sagte:<\/p>\n

\n

\u201cVanguard Life Sciences stellt eine spannende Gelegenheit dar, die Expertise, die Vanguard in mehr als zwei Jahrzehnten aufgebaut hat, in einem anderen stark regulierten Umfeld anzuwenden, in dem Qualit\u00e4t, Schnelligkeit und Flexibilit\u00e4t von enormer Bedeutung sind.\u201d<\/p>\n<\/blockquote>\n

Als Group CEO wird Rebecca Vanguard Life Sciences gemeinsam leiten. Vanguard Healthcare-L\u00f6sungen<\/a> und die internationalen Gesundheitsaktivit\u00e4ten der Gruppe durch Q-bital-L\u00f6sungen f\u00fcr das Gesundheitswesen<\/a>.<\/p>\n

Ihre Ernennung erfolgt zu einem Zeitpunkt, an dem Vanguard Life Sciences seine Pr\u00e4senz in diesem Sektor weiter ausbaut und L\u00f6sungen entwickelt, die spezialisiertes technisches Fachwissen mit den Vorteilen moderner Bauweisen verbinden.<\/p>\n

Rebecca sprach auch \u00fcber die sich daraus ergebenden Chancen f\u00fcr die Gruppe und f\u00fcgte hinzu:<\/p>\n

\n

\u201c\u00dcber unser etabliertes Gesundheitsgesch\u00e4ft in Gro\u00dfbritannien hinaus besteht erhebliches Potenzial. Ich freue mich \u00fcber die kontinuierliche internationale Entwicklung von Q-bital und \u00fcber die M\u00f6glichkeit, die Vanguard Life Sciences uns bietet, unsere Erfahrung mit komplexen, regulierten Umgebungen in einem neuen Markt anzuwenden.\u201d<\/p>\n<\/blockquote>\n

Dr. Graham Rich, Vorsitzender von Vanguard Healthcare Solutions, sagte:<\/p>\n

\n

\u201cRebecca vereint auf au\u00dfergew\u00f6hnliche Weise F\u00fchrungskompetenz im Gesundheitswesen, strategisches Geschick und Erfahrung im Aufbau qualitativ hochwertiger klinischer Dienstleistungen.\u201c.<\/p>\n

\u201cIch freue mich sehr, Rebecca als Leiterin des Unternehmens in der n\u00e4chsten Entwicklungsphase begr\u00fc\u00dfen zu d\u00fcrfen.\u201d<\/p>\n<\/blockquote>\n

Wir freuen uns sehr, Rebecca in der Vanguard-Gruppe begr\u00fc\u00dfen zu d\u00fcrfen und blicken gespannt auf das n\u00e4chste Kapitel f\u00fcr Vanguard Life Sciences, w\u00e4hrend wir unsere Kompetenzen und Partnerschaften in den Bereichen Pharmazie, Biotechnologie und Forschung weiterentwickeln.<\/strong><\/p>","protected":false},"excerpt":{"rendered":"

Vanguard Life Sciences freut sich, Rebecca Lythe als Chief Executive Officer der Vanguard Group begr\u00fc\u00dfen zu d\u00fcrfen. Sie wird die Position ab dem 1. September 2026 \u00fcbernehmen.<\/p>","protected":false},"author":11,"featured_media":8825,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8824","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"yoast_head":"\nVanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer - Vanguard Life Sciences<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer - Vanguard Life Sciences\" \/>\n<meta property=\"og:description\" content=\"Vanguard Life Sciences is delighted to welcome Rebecca Lythe as Chief Executive Officer of the Vanguard Group, as she takes up the role from 1 September 2026.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Vanguard Life Sciences\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-01T08:44:13+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-01T08:44:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/09\/Rebecca-L-Headshot-VLS.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"chrissybligh\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"chrissybligh\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/\"},\"author\":{\"name\":\"chrissybligh\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#\\\/schema\\\/person\\\/a7817235898449de836f9c0de1c782d5\"},\"headline\":\"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer\",\"datePublished\":\"2026-09-01T08:44:13+00:00\",\"dateModified\":\"2026-09-01T08:44:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/\"},\"wordCount\":406,\"image\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/09\\\/Rebecca-L-Headshot-VLS.png\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"de-DE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/\",\"url\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/\",\"name\":\"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer - Vanguard Life Sciences\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/09\\\/Rebecca-L-Headshot-VLS.png\",\"datePublished\":\"2026-09-01T08:44:13+00:00\",\"dateModified\":\"2026-09-01T08:44:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#\\\/schema\\\/person\\\/a7817235898449de836f9c0de1c782d5\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/09\\\/Rebecca-L-Headshot-VLS.png\",\"contentUrl\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/wp-content\\\/uploads\\\/sites\\\/9\\\/2026\\\/09\\\/Rebecca-L-Headshot-VLS.png\",\"width\":1200,\"height\":1200},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#website\",\"url\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/\",\"name\":\"Vanguard Life Sciences\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de-DE\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.vanguardlifesciences.co.uk\\\/#\\\/schema\\\/person\\\/a7817235898449de836f9c0de1c782d5\",\"name\":\"chrissybligh\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68263e1def00912ffced2190270fc09ca3bf608ccf0a2d6ad1fde586b4e54b10?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68263e1def00912ffced2190270fc09ca3bf608ccf0a2d6ad1fde586b4e54b10?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/68263e1def00912ffced2190270fc09ca3bf608ccf0a2d6ad1fde586b4e54b10?s=96&d=mm&r=g\",\"caption\":\"chrissybligh\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer - Vanguard Life Sciences","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/","og_locale":"de_DE","og_type":"article","og_title":"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer - Vanguard Life Sciences","og_description":"Vanguard Life Sciences is delighted to welcome Rebecca Lythe as Chief Executive Officer of the Vanguard Group, as she takes up the role from 1 September 2026.","og_url":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/","og_site_name":"Vanguard Life Sciences","article_published_time":"2026-09-01T08:44:13+00:00","article_modified_time":"2026-09-01T08:44:32+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/09\/Rebecca-L-Headshot-VLS.png","type":"image\/png"}],"author":"chrissybligh","twitter_card":"summary_large_image","twitter_misc":{"Verfasst von":"chrissybligh","Gesch\u00e4tzte Lesezeit":"2 Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#article","isPartOf":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/"},"author":{"name":"chrissybligh","@id":"https:\/\/www.vanguardlifesciences.co.uk\/#\/schema\/person\/a7817235898449de836f9c0de1c782d5"},"headline":"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer","datePublished":"2026-09-01T08:44:13+00:00","dateModified":"2026-09-01T08:44:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/"},"wordCount":406,"image":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/09\/Rebecca-L-Headshot-VLS.png","articleSection":["Uncategorized"],"inLanguage":"de-DE"},{"@type":"WebPage","@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/","url":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/","name":"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer - Vanguard Life Sciences","isPartOf":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#primaryimage"},"image":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/09\/Rebecca-L-Headshot-VLS.png","datePublished":"2026-09-01T08:44:13+00:00","dateModified":"2026-09-01T08:44:32+00:00","author":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/#\/schema\/person\/a7817235898449de836f9c0de1c782d5"},"breadcrumb":{"@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/"]}]},{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#primaryimage","url":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/09\/Rebecca-L-Headshot-VLS.png","contentUrl":"https:\/\/www.vanguardlifesciences.co.uk\/wp-content\/uploads\/sites\/9\/2026\/09\/Rebecca-L-Headshot-VLS.png","width":1200,"height":1200},{"@type":"BreadcrumbList","@id":"https:\/\/www.vanguardlifesciences.co.uk\/vanguard-life-sciences-welcomes-rebecca-lythe-as-group-chief-executive-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vanguardlifesciences.co.uk\/"},{"@type":"ListItem","position":2,"name":"Vanguard Life Sciences welcomes Rebecca Lythe as Group Chief Executive Officer"}]},{"@type":"WebSite","@id":"https:\/\/www.vanguardlifesciences.co.uk\/#website","url":"https:\/\/www.vanguardlifesciences.co.uk\/","name":"Vanguard Life Sciences","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vanguardlifesciences.co.uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de-DE"},{"@type":"Person","@id":"https:\/\/www.vanguardlifesciences.co.uk\/#\/schema\/person\/a7817235898449de836f9c0de1c782d5","name":"chrissybligh","image":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/secure.gravatar.com\/avatar\/68263e1def00912ffced2190270fc09ca3bf608ccf0a2d6ad1fde586b4e54b10?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/68263e1def00912ffced2190270fc09ca3bf608ccf0a2d6ad1fde586b4e54b10?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/68263e1def00912ffced2190270fc09ca3bf608ccf0a2d6ad1fde586b4e54b10?s=96&d=mm&r=g","caption":"chrissybligh"}}]}},"_links":{"self":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/wp-json\/wp\/v2\/posts\/8824","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/wp-json\/wp\/v2\/comments?post=8824"}],"version-history":[{"count":2,"href":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/wp-json\/wp\/v2\/posts\/8824\/revisions"}],"predecessor-version":[{"id":8827,"href":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/wp-json\/wp\/v2\/posts\/8824\/revisions\/8827"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/wp-json\/wp\/v2\/media\/8825"}],"wp:attachment":[{"href":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/wp-json\/wp\/v2\/media?parent=8824"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/wp-json\/wp\/v2\/categories?post=8824"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vanguardlifesciences.co.uk\/de_de\/wp-json\/wp\/v2\/tags?post=8824"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}